3i Infotech Limited Approves Grant of 1,99,000 Stock Options under ESOS 2018
3i Infotech Limited announced that its Nomination and Remuneration Committee, in a meeting held on April 28, 2026, approved the grant of stock options to its identified employee(s). The options are issued under the company's 3i Infotech Stock Option Scheme 2018 (ESOS 2018).The approved grant involves 1,99,000 stock options, covering an equivalent total number of 1,99,000 equity shares. The scheme has been structured in line with the requirements of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The detailed terms and conditions of the stock option grant are outlined below:
| Particular | Detail |
|---|---|
| Options Granted | 1,99,000 stock options |
| Scheme | 3i Infotech Stock Option Scheme 2018 (ESOS 2018) |
| Total Shares Covered | 1,99,000 equity shares |
| Pricing Formula | Rs. 10/- per stock option |
| Vesting Schedule | Year 1: 33%, Year 2: 33%, Year 3: 34% |
| Exercise Period | 5 years from the vesting date |
The ESOS 2018 governs how stock options will be handled in various scenarios, including death, permanent incapacity, resignation, or termination. The accompanying equity shares, upon exercise of the stock options, are stipulated to be pari passu to existing Equity shares in all respects and will not be subject to any lock in period.
The scheme terms also clarify that the options are currently not applicable for exercise, realization, or lapsation.
3IINFOLTD Stock Price Movement
As of 2:09 PM, shares of 3i Infotech Limited are slipping by 0.45% in live trading, currently at ₹17.65. The stock has traded in a range of ₹17.58 to ₹17.85 today, amidst 195,777 shares changing hands.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.